Amniotic Products Market

Amniotic Products Market by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions], Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospital, ASCs) - Global Forecast to 2025

Report Code: MD 7637 May, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Amniotic Products Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Amniotic Products Market

Request For Special Pricing

[126 Pages Report] The global amniotic products market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%. Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments. The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.

Amniotic Products Market

The wound care segment dominated the amniotic products market in 2019.

Based on application, the amniotic products market is categorized into wound care, ophthalmology, orthopedics, and other applications. Wound care was the largest application segment in the amniotic products market in 2019 and is expected to grow at the highest CAGR during the forecast period. Growth in this market is largely driven by the rising prevalence of diabetic foot ulcers, venous leg ulcers, surgical & traumatic wounds, and burn injuries.

The hospital & ASCs segment is expected to register the highest CAGR during the forecast period.

On the basis of end user, the amniotic products market is segmented into hospitals & ASCs and other end users. In 2019, hospitals & ASCs accounted for the largest share of the amniotic products market and are expected to register the highest CAGR. Growth in this segment can primarily be attributed to factors such as the high demand for wound care biologics (including amniotic tissue products) in hospitals and ASCs, the high patient inflow in this care setting, and the availability of reimbursements.

Amniotic Products Market

North America was the largest regional market for amniotic products in 2019.

The amniotic products market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America was the largest market, followed by Europe. This can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players of amniotic products in this region. The presence of a well-established healthcare system and ongoing investments by hospitals to upgrade & expand their operating capabilities are other factors supporting market growth in North America.

Key Market Players

The prominent players operating in this market include MiMedx (US), Smith & Nephew (UK), Organogenesis (US), Integra LifeSciences Corporation (US), Stryker Corporation (US), Wright Medical (Netherlands), Applied Biologics (US), Celularity (US), Katena Products (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics (US), Surgenex (US), TissueTech (US), Ventris Medical (US), StimLabs (US), VIVEX Biologics (US), LifeCell International (India), NuVision Biotherapies (England), and Genesis Biologics (US).

MiMedx was one of the leading players in the amniotic products market in 2019. This can be attributed to its wide range of amniotic-based product offerings. The company has supplied more than 1.8 million placental tissue-based allografts for various applications in the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. A significant portion of the firm’s revenue comes from the government since the company provides sales for the same.

Scope of the Report:

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2018

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Type, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

MiMedx (US), Smith & Nephew (UK), Organogenesis (US), and Integra LifeSciences Corporation (US). Other players include Stryker Corporation (US), Wright Medical (Netherlands), Applied Biologics (US), Celularity (US), Katena Products (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics (US), Surgenex (US), TissueTech (US), Ventris Medical (US), StimLabs (US), VIVEX Biologics (US), LifeCell International (India), NuVision Biotherapies (England), and Genesis Biologics (US).

This report categorizes the amniotic products market into the following segments and subsegments:

Amniotic Products Market, by Type

  • Amniotic Membranes
    • Cryopreserved Amniotic Membranes    
    • Dehydrated Amniotic Membranes ;
  • Amniotic Suspensions

Amniotic Products Market, by Application

  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Other Applications (periodontal applications and other research applications)

Amniotic Products Market, by End User

  • Hospitals & ASCs
  • Other End Users (medical research and laboratories)

Amniotic Products Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In 2019, Smith & Nephew acquired Osiris Therapeutics, complementing the company’s advanced wound management unit by offering regenerative medicine products inclusive of skin, bone graft, and articular cartilage substitutes.
  • In 2018, the US FDA granted the Regenerative Medicine Advanced Therapy (RMAT) designation to MiMedx’s AmnioFix Injectable for use in the treatment of osteoarthritis (OA) of the knee.
  • In 2017, Organogenesis acquired NuTech to support the firm’s development of next-generation amniotic products. The newly-combined company offers a portfolio of advanced next-generation products for the wound care and surgical biologics markets.

Key Questions Addressed by the Report

  • Where will all these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting the amniotic products market?
  • Who are the major end users in the amniotic products market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the key types of amniotic products in the market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 15)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 18)
    2.1 RESEARCH DATA
    2.2 SECONDARY DATA
           2.2.1 SECONDARY SOURCES
    2.3 PRIMARY DATA
           2.3.1 KEY DATA FROM PRIMARY SOURCES
    2.4 MARKET SIZE ESTIMATION
           2.4.1 BOTTOM-UP APPROACH
           2.4.2 GROWTH FORECAST
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 25)

4 PREMIUM INSIGHTS (Page No. - 29)
    4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
    4.2 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    4.3 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    4.4 AMNIOTIC PRODUCTS MARKET, BY END USER, 2019
    4.5 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. - 32)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Growth in the target patient population
                    5.2.1.2 Rising incidence of burn injuries
                    5.2.1.3 Awareness programs for wound care treatment and management
                    5.2.1.4 Rise in venture capital investment and government funding
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Emerging economies
                    5.2.2.2 Implementation of the 21st Century Cures Act (US)
           5.2.3 CHALLENGES
                    5.2.3.1 Complications and limitations associated with the use of amniotic membranes

6 AMNIOTIC PRODUCTS MARKET, BY TYPE (Page No. - 38)
    6.1 INTRODUCTION
    6.2 AMNIOTIC MEMBRANES
           6.2.1 CRYOPRESERVED AMNIOTIC MEMBRANES
                    6.2.1.1 Cryopreserved amniotic membranes to dominate the market during the forecast period
           6.2.2 DEHYDRATED AMNIOTIC MEMBRANES
                    6.2.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
    6.3 AMNIOTIC SUSPENSIONS
           6.3.1 ANTI-ADHESIVE, ANTI-INFLAMMATORY, AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE GROWTH

7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION (Page No. - 47)
    7.1 INTRODUCTION
    7.2 WOUND CARE
           7.2.1 WOUND CARE APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE AMNIOTIC PRODUCTS MARKET
    7.3 ORTHOPEDICS
           7.3.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
    7.4 OPHTHALMOLOGY
           7.4.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
    7.5 OTHER APPLICATIONS

8 AMNIOTIC PRODUCTS MARKET, BY REGION (Page No. - 56)
    8.1 INTRODUCTION
    8.2 NORTH AMERICA
           8.2.1 US
                    8.2.1.1 The US to dominate the North American amniotic products market during the forecast period
           8.2.2 CANADA
                    8.2.2.1 Rising prevalence of target diseases to drive market growth
    8.3 EUROPE
           8.3.1 UK
                    8.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2019
           8.3.2 GERMANY
                    8.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
           8.3.3 FRANCE
                    8.3.3.1 Rising government support to drive the market demand for amniotic products in France
           8.3.4 REST OF EUROPE
    8.4 ASIA PACIFIC
           8.4.1 CHINA
                    8.4.1.1 China to dominate the Asia Pacific market during the forecast period
           8.4.2 JAPAN
                    8.4.2.1 Growing geriatric population to drive market growth in Japan
           8.4.3 ROAPAC
    8.5 ROW

9 COMPETITIVE LANDSCAPE (Page No. - 85)
    9.1 OVERVIEW
    9.2 MARKET SHARE ANALYSIS, 2018
    9.3 COMPETITIVE SCENARIO
           9.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
           9.3.2 PRODUCT LAUNCHES & APPROVALS
           9.3.3 EXPANSIONS
           9.3.4 ACQUISITIONS
    9.4 COMPETITIVE LEADERSHIP MAPPING (2019)
           9.4.1 VENDOR INCLUSION CRITERIA
           9.4.2 VISIONARY LEADERS
           9.4.3 INNOVATORS
           9.4.4 DYNAMIC DIFFERENTIATORS
           9.4.5 EMERGING COMPANIES

10 COMPANY PROFILES (Page No. - 93)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     10.1 MIMEDX
     10.2 SMITH & NEPHEW
     10.3 ORGANOGENESIS INC.
     10.4 INTEGRA LIFESCIENCES CORPORATION
     10.5 STRYKER CORPORATION
     10.6 WRIGHT MEDICAL GROUP
     10.7 APPLIED BIOLOGICS
     10.8 CELULARITY, INC.
     10.9 KATENA PRODUCTS, INC.
     10.10 LUCINA BIOSCIENCES
     10.11 NEXT BIOSCIENCES
     10.12 SKYE BIOLOGICS INC.
     10.13 SURGENEX
     10.14 TISSUETECH, INC.
     10.15 VENTRIS MEDICAL, LLC
     10.16 STIMLABS LLC
     10.17 VIVEX BIOLOGICS, INC.
     10.18 LIFECELL INTERNATIONAL PVT. LTD.
     10.19 NUVISION BIOTHERAPIES LIMITED
     10.20 GENESIS BIOLOGICS
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies. 

11 APPENDIX (Page No. - 120)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 AVAILABLE CUSTOMIZATIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS


LIST OF TABLES (101 Tables)

TABLE 1 GLOBAL PREVALENCE OF DIABETES
TABLE 2 WOUND CARE AWARENESS INITIATIVES
TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER THE 21ST CENTURY CURES ACT
TABLE 4 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 AMNIOTIC MEMBRANES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 AMNIOTIC MEMBRANES MARKET, BY REGION, 2018–2025 (MILLION UNITS)
TABLE 8 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 EUROPE: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 NORTH AMERICA: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 EUROPE: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 ASIA PACIFIC: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 NORTH AMERICA: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 EUROPE: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 ASIA PACIFIC: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 NORTH AMERICA: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 ASIA PACIFIC: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 EUROPE: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 EUROPE: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 AMNIOTIC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 46 US: KEY MACROINDICATORS
TABLE 47 US: KEY MICROINDICATORS
TABLE 48 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 51 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 52 US: AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 CANADA: KEY MACROINDICATORS
TABLE 54 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 57 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 63 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 66 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 67 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 71 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 75 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2006 VS. 2016 (% OF GDP)
TABLE 76 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 80 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 81 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 88 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 92 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 96 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 97 ROW: DIABETIC POPULATION, BY REGION
TABLE 98 ROW: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ROW: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 ROW: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 101 ROW: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)


LIST OF FIGURES (29 Figures)

FIGURE 1 AMNIOTIC PRODUCTS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION FROM PARENT MARKET
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2025 (USD MILLION)
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AMNIOTIC PRODUCTS MARKET
FIGURE 11 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 CRYOPRESERVED AMNIOTIC MEMBRANES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 13 WOUND CARE APPLICATIONS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 14 HOSPITALS & ASCS TO BE THE LARGEST END USERS OF AMNIOTIC PRODUCTS DURING THE FORECAST PERIOD
FIGURE 15 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 AMNIOTIC MEMBRANE RESEARCH PUBLICATIONS
FIGURE 18 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT
FIGURE 19 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
FIGURE 21 MARKET EVOLUTION FRAMEWORK
FIGURE 22 AMNIOTIC PRODUCTS MARKET, BY KEY PLAYER, 2018
FIGURE 23 MNM VENDOR DIVE COMPARISON MATRIX: AMNIOTIC PRODUCTS MARKET
FIGURE 24 COMPANY SNAPSHOT: MIMEDX
FIGURE 25 COMPANY SNAPSHOT: SMITH & NEPHEW
FIGURE 26 COMPANY SNAPSHOT: ORGANOGENESIS INC.
FIGURE 27 COMPANY SNAPSHOT: INTEGRA LIFESCIENCES (2019)
FIGURE 28 COMPANY SNAPSHOT: STRYKER CORPORATION
FIGURE 29 COMPANY SNAPSHOT: WRIGHT MEDICAL GROUP

This study involved four major activities in estimating the current size of the amniotic products market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the amniotic products market. The secondary sources used for this study include Food and Drug Administration (FDA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), Organisation for Economic Co-operation and Development (OECD), Association for the Advancement of Wound Care (AAWC), Journal of Wound Care (JWC), American Physical Therapy Association (APTA), National Alliance of Wound Care (NAWC), European Wound Management Association (EWMA), National Institute for Health and Care Excellence (NICE), Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Amniotic Products Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the amniotic products market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the amniotic products business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global amniotic products market based on type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall amniotic products market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, and Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions; new product launches; expansions; agreements, partnerships, and collaborations; and R&D activities in the amniotic products market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • Additional five company profiles
Report Code
MD 7637
Published ON
May, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Amniotic Products Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home